Literature DB >> 32397025

[Prognostic significance of minimal residual disease before post-remission therapy in younger adult acute myeloid leukemia patients with intermediate risk and negative of FLT3-ITD, NPM1 and biallelic CEBPA mutations].

Y Zhang1, Y M Zhang, Y S Zhang, G S Tang, W P Zhang, J M Yang, J M Wang, X X Hu.   

Abstract

Entities:  

Year:  2019        PMID： 32397025     DOI： 10.3760/cma.j.issn.0253-2727.2019.07.012

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN： 0253-2727


× No keyword cloud information.
  1 in total

1.  HLX affects cell cycle and proliferation in AML cells via the JAK/STAT signaling pathway.

Authors:  Xia-Yin Zhu; Qun-Yi Guo; Min Zhu; Bao-Guo Chen; Ling-Yan Wang; Dan-Qiong Zhang; Li Zhang; Yan-Ping Shao; Wen-Da Luo
Journal:  Oncol Lett       Date:  2020-06-09       Impact factor: 2.967
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.